Table 1 Baseline characteristics (LSD)
Group A FCT ≤ 65 μm (n = 147) | Group B 65 < FCT ≤ 80 μm (n = 84) | Group C FCT > 80 μm(n = 271) | P-value | |
|---|---|---|---|---|
Age, years | 66.0 ± 11.5 | 65.4 ± 10.7 | 65.6 ± 10.3 | 0.921 |
Male, n (%) | 127 (86.4) | 70 (83.3) | 220 (81.2) | 0.397 |
Current smoker, n (%) | 66 (44.9) | 32 (38.1) | 95 (35.1) â–³ | 0.142 |
Hypertension, n (%) | 102 (69.4) | 59 (70.2) | 173 (63.8) | 0.379 |
Hypercholesterolaemia, n (%) | 81 (55.1) | 45 (53.6) | 157 (57.9) | 0.729 |
Diabetes mellitus, n (%) | 45 (30.6) | 28 (33.3) | 92 (33.9) | 0.782 |
Haemodialysis, n (%) | 3 (2.0) | 1 (1.2) | 9 (3.3) | 0.591 |
Previous MI, n (%) | 14 (9.5) | 12 (14.3) | 56 (20.7) â–³ | 0.011 |
Previous PCI, n (%) | 19 (12.9) | 19 (22.6) | 73 (26.9) â–³ | 0.004 |
Previous CABG, n (%) | 3 (2.0) | 2 (2.4) | 3 (1.1) | 0.504 |
Indication for index PCI, n (%) | ||||
 SAP | 32 (21.8) | 37 (44.0) * | 176 (64.9) #△ | < 0.001 |
 ACS | 115 (78.2) | 47 (56.0) * | 95 (35.1) #△ | < 0.001 |
Laboratory results | ||||
 TC, mg/dl | 194.9 ± 42.5 | 185.9 ± 34.0 | 180.2 ± 38.8 △ | 0.001 |
 LDL-C, mg/dl | 123.0 ± 36.7 | 113.7 ± 27.5 * | 107.6 ± 34.2 △ | < 0.001 |
 HDL-C, mg/dl | 44.4 ± 11.4 | 44.3 ± 9.8 | 46.3 ± 11.6 | 0.172 |
 Triglyceride, mg/dl | 132.3 ± 84.0 | 131.2 ± 91.2 | 133.6 ± 71.2 | 0.968 |
 Creatinine, mg/dl | 0.99 ± 0.97 | 0.89 ± 0.58 | 1.12 ± 1.56 # | 0.286 |
 eGFR, ml/(min × 1.73 m2) | 72.5 ± 23.6 | 71.9 ± 18.9 | 70.8 ± 23.8 | 0.770 |
 hs-CRP, mg/L | 0.50 ± 0.93 | 0.37 ± 0.61 | 0.35 ± 0.91 | 0.082 |
 HbA1c, % | 6.1 ± 1.4 | 5.9 ± 0.82 | 6.0 ± 1.2 | 0.628 |
Previous medications, n (%) | ||||
 Statins | 10 (6.8) | 12 (14.3) | 52 (19.2) △ | 0.003 |